| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |